Passa al contenuto
Merck

Vai a

1A01050

USP

6-Methyl-4-Phenylchromanol

Pharmaceutical Analytical Impurity (PAI)

Sinonimo/i:

(6-Methyl-4-phenylchroman-2-ol)

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
A voi/SKUDisponibilitàPrezzo
25 mg
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
1.260,00 €

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C16H16O2
Numero CAS:
Peso molecolare:
240.30
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107

1.260,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.

Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


grade

pharmaceutical analytical impurity (PAI)

agency

USP

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

General description

[6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol)] - CAS [209747-04-6] (usp.org)6-Methyl-4-Phenylchromanol is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Tolterodine tartrate.

Therapeutic Area: Renal.

For more information about this PAI, visit here.

Application

6-Methyl-4-Phenylchromanol (USP PAI) is intendedfor use in analytical testing to detect, identify, and measure pharmaceuticalimpurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
1A01060W466620552852
grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

grade

FG, Kosher, natural

grade

-

manufacturer/tradename

USP

manufacturer/tradename

USP

manufacturer/tradename

-

manufacturer/tradename

-

application(s)

pharmaceutical

application(s)

pharmaceutical

application(s)

-

application(s)

-

format

neat

format

neat

format

-

format

-

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

-

agency

USP

agency

USP

agency

meets purity specifications of JECFA

agency

-


Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Domande

Recensioni

Nessuna valutazione

Filtri attivi